![Bryan Ball](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Ball
Chief Tech/Sci/R&D Officer at
WHITEHAWK THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Bryan Ball is currently Chief Technical Operations Officer at Whitehawk Therapeutics, Inc. since 2024.
Former positions include Chief Quality Officer at Immunomedics, Inc., Chief Quality Officer & Senior VP-Operations at Intercept Pharmaceuticals, Inc. from 2021 to 2022, Vice President-Global Quality at Ikaria, Inc. from 2012 to 2015, Vice President-Quality & Regulatory at Ben Venue Laboratories, Inc., and SVP-Global Quality, Environmental Health & Safety at Mallinckrodt LLC from 2015 to 2019.
Education includes undergraduate studies at Central Michigan University, an MBA from Westminster School, and graduate studies at The University of North Carolina at Charlotte.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-13 | 448,126 ( 0.95% ) | 2 M $ | 2026-05-30 |
Bryan Ball active positions
| Companies | Position | Start |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-02-29 |
Former positions of Bryan Ball
| Companies | Position | End |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Chief Operating Officer | 2022-07-31 |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 2018-12-31 |
| IKARIA, INC. | Corporate Officer/Principal | 2014-12-31 |
Ben Venue Laboratories, Inc.
 Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Corporate Officer/Principal | - |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | - |
Training of Bryan Ball
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Health Technology |
Central Michigan University
 Central Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Westminster School
 Westminster School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Bryan Ball
Choose MarketScreener 
